AU7830398A - Human tumor necrosis factor receptor tr9 - Google Patents

Human tumor necrosis factor receptor tr9

Info

Publication number
AU7830398A
AU7830398A AU78303/98A AU7830398A AU7830398A AU 7830398 A AU7830398 A AU 7830398A AU 78303/98 A AU78303/98 A AU 78303/98A AU 7830398 A AU7830398 A AU 7830398A AU 7830398 A AU7830398 A AU 7830398A
Authority
AU
Australia
Prior art keywords
necrosis factor
tumor necrosis
factor receptor
human tumor
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78303/98A
Inventor
Ping Fan
Reiner L Gentz
Jian Ni
Guo-Liang Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU7830398A publication Critical patent/AU7830398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
AU78303/98A 1997-06-11 1998-06-10 Human tumor necrosis factor receptor tr9 Abandoned AU7830398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5299197P 1997-06-11 1997-06-11
US60052991 1997-06-11
PCT/US1998/011932 WO1998056892A1 (en) 1997-06-11 1998-06-10 Human tumor necrosis factor receptor tr9

Publications (1)

Publication Number Publication Date
AU7830398A true AU7830398A (en) 1998-12-30

Family

ID=21981206

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78303/98A Abandoned AU7830398A (en) 1997-06-11 1998-06-10 Human tumor necrosis factor receptor tr9

Country Status (5)

Country Link
EP (1) EP0988371A4 (en)
JP (1) JP2002503963A (en)
AU (1) AU7830398A (en)
CA (1) CA2295991A1 (en)
WO (1) WO1998056892A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888466B2 (en) 1996-01-11 2011-02-15 Human Genome Sciences, Inc. Human G-protein chemokine receptor HSATU68
US7357927B2 (en) 1996-03-12 2008-04-15 Human Genome Sciences, Inc. Death domain containing receptors
WO1997033904A1 (en) 1996-03-12 1997-09-18 Human Genome Sciences, Inc. Death domain containing receptors
US6713061B1 (en) 1996-03-12 2004-03-30 Human Genome Sciences, Inc. Death domain containing receptors
US7964190B2 (en) 1996-03-22 2011-06-21 Human Genome Sciences, Inc. Methods and compositions for decreasing T-cell activity
US6635743B1 (en) 1996-03-22 2003-10-21 Human Genome Sciences, Inc. Apoptosis inducing molecule II and methods of use
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
JP2001507937A (en) 1997-01-14 2001-06-19 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Tumor necrosis factor receptor 6α and tumor necrosis factor receptor 6β
US6358508B1 (en) 1997-06-11 2002-03-19 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor TR9
US6949358B1 (en) 1997-06-11 2005-09-27 Human Genome Sciences, Inc. Human tumor necrosis factor receptor TR9
US6194151B1 (en) 1997-09-26 2001-02-27 Millenium Pharmaceuticals, Inc. Molecules of the TNF receptor superfamily and uses therefor
GB9812607D0 (en) * 1998-06-12 1998-08-12 Zeneca Ltd Protein
US6916907B1 (en) 1998-10-23 2005-07-12 Curagen Corporation Nucleic acids encoding osteoprotegern-like proteins and methods of using same
JP2002531112A (en) * 1998-12-11 2002-09-24 ブリストル−マイヤーズ スクイブ カンパニー Tumor necrosis factor receptor homolog-1
CA2363779A1 (en) 1999-02-26 2000-08-31 Human Genome Sciences, Inc. Human endokine alpha and methods of use
WO2000056862A1 (en) * 1999-03-24 2000-09-28 Human Genome Sciences, Inc. Human tumor necrosis factor receptor tr9
CN100390288C (en) 2000-04-11 2008-05-28 杰南技术公司 Multivalent antibodies and uses therefor
CA2405701A1 (en) 2000-04-12 2001-10-25 Human Genome Sciences, Inc. Albumin fusion proteins
WO2001085209A2 (en) * 2000-05-10 2001-11-15 Eli Lilly And Company Treating t-cell mediated diseases by modulating dr6 activity
EP1294949A4 (en) 2000-06-15 2004-08-25 Human Genome Sciences Inc Human tumor necrosis factor delta and epsilon
KR101155294B1 (en) 2000-06-16 2013-03-07 캠브리지 안티바디 테크놀로지 리미티드 Antibodies that immunospecifically bind to BLyS
KR100942393B1 (en) 2001-05-25 2010-02-17 휴먼 게놈 사이언시즈, 인코포레이티드 Antibodies that immunospecifically bind to TRAIL receptors
CA2471363C (en) 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
JO3000B1 (en) 2004-10-20 2016-09-05 Genentech Inc Antibody Formulations.
EP1933873A4 (en) 2005-10-13 2009-12-02 Human Genome Sciences Inc Methods and compositions for use in treatment of patients with autoantibody positive diseases
CN102227501B (en) 2008-09-26 2016-11-16 托卡根公司 Gene therapy vector and cytosine deaminase
WO2010062904A2 (en) 2008-11-25 2010-06-03 Biogen Idec Ma Inc. Use of dr6 and p75 antagonists to promote survival of cells of the nervous system
AU2011329647B2 (en) 2010-11-19 2015-10-22 Eisai R&D Management Co., Ltd. Neutralizing anti-CCL20 antibodies
ES2786051T3 (en) 2012-10-25 2020-10-08 Tocagen Inc Retroviral vector with mini-promoter cassette
MX2022006670A (en) 2019-12-03 2023-03-17 Shanghai Jiao Tong Univ School Of Medicine Antibody fc region having enhanced fcî³riib affinity.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
EP0394827A1 (en) 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimaeric CD4-immunoglobulin polypeptides
US5462856A (en) 1990-07-19 1995-10-31 Bunsen Rush Laboratories, Inc. Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
WO1994009137A1 (en) 1992-10-15 1994-04-28 Genentech, Inc. Antibodies against type 2 tumor necrosis factor receptor
US6358508B1 (en) * 1997-06-11 2002-03-19 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor TR9
WO1999011790A1 (en) * 1997-09-04 1999-03-11 Zymogenetics, Inc. Tumor necrosis factor receptor ztnfr-6
WO2000056862A1 (en) * 1999-03-24 2000-09-28 Human Genome Sciences, Inc. Human tumor necrosis factor receptor tr9

Also Published As

Publication number Publication date
WO1998056892A1 (en) 1998-12-17
EP0988371A1 (en) 2000-03-29
JP2002503963A (en) 2002-02-05
CA2295991A1 (en) 1998-12-17
EP0988371A4 (en) 2002-11-04

Similar Documents

Publication Publication Date Title
AU7830398A (en) Human tumor necrosis factor receptor tr9
AU9013998A (en) Tumor necrosis factor receptor ztnfr-5
AU2363695A (en) Human tumor necrosis factor receptors
AU7705198A (en) Human tumor necrosis factor receptor tr10
EP1007562A4 (en) TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
AUPO203996A0 (en) Therapeutic uses
AU6042298A (en) Tissue factor pathway inhibitor-3
ZA952587B (en) Human tumor necrosis factor receptor
AU7705098A (en) Human tumor necrosis factor receptor-like protein 8
AU3766700A (en) Human tumor necrosis factor receptor-like 2
AU7607098A (en) New human ribonuclease
AU1541699A (en) Human tumor necrosis factor-r2-like proteins
AU1118299A (en) Pharmaceutical grade garlic
AU9130598A (en) Tumor necrosis factor receptor ztnfr-6
AU7089800A (en) 29 human cancer associated proteins
AU9017598A (en) Human frezzled-like protein
AU6035398A (en) Human c5a-like receptor
AU5471098A (en) Bone stimulating factor
EP1009431A4 (en) Human tumor necrosis factor receptor-like 2 (tr2) antibodies
AU5022400A (en) Tumor necrosis factor receptor 5
AU3628800A (en) Human tumor necrosis factor receptor tr9
AU8019494A (en) Human endothelin-bombesin receptor
AU4849299A (en) Human emr1-like g protein coupled receptor
AU1645599A (en) Human matrilin-3
AU8155898A (en) Human preprotachykinin b

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase